Therapeutic Area | MeSH |
---|---|
infections | D007239 |
otorhinolaryngologic diseases | D010038 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Otitis | D010031 | — | — | 1 | 1 | 2 | — | — | 4 |
Otitis externa | D010032 | EFO_0009560 | H60 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Otitis media | D010033 | EFO_0004992 | H66.9 | 1 | 1 | — | — | — | 2 |
Drug common name | Finafloxacin |
INN | finafloxacin |
Description | Finafloxacin is a quinolone that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted at positions 1, 6, 7 and 8 by cyclopropyl, fluoro, hexahydropyrrolo[3,4-b][1,4]oxazin-6-yl and cyano groups respectively; an antibiotic used for treatment of acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus. It has a role as an antimicrobial agent and an antibacterial drug. It is a quinolone, a monocarboxylic acid, an organofluorine compound, a secondary amino compound, a tertiary amino compound, a nitrile and a member of cyclopropanes. |
Classification | Small molecule |
Drug class | antibacterials (quinolone derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12 |
PDB | — |
CAS-ID | 209342-40-5 |
RxCUI | — |
ChEMBL ID | CHEMBL1908370 |
ChEBI ID | 85176 |
PubChem CID | 11567473 |
DrugBank | — |
UNII ID | D26OSN9Q4R (ChemIDplus, GSRS) |